EUGENEX Biotechnologies
Your experienced partner for optimized cell lines and process development
At EUGENEX Biotechnologies, we generate expression cell lines and processes for the animal component-free (ACF) production of biosimilars and novel biopharmaceuticals. Our proprietary technology platform delivers excellent yields with high product quality. Through our expertise in regulatory issues and biosafety, our products are designed for a simplified FDA or EMA approval. Currently, more than 12 biopharmaceuticals derived from EUGENEX’ cell lines provide people worldwide with affordable, high-quality medicine.